LABU Short Volume
Direxion Daily S&P Biotech Bull 3X Shares (LABU) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $1.47B, listed on AMEX, carrying a beta of 3.21 to the broader market. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. public since 2015-05-28.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-30
- Short Volume
- 99.7K
- Total Volume
- 203.6K
- Short %
- 48.95%
- 30-Day Avg Short %
- 47.66%
Showing 30 days of FINRA short volume data for Direxion Daily S&P Biotech Bull 3X Shares.
Learn how short volume is reported and how to read the data →
Frequently asked LABU short volume questions
- What is the daily LABU short volume?
- As of Jun 30, 2026, Direxion Daily S&P Biotech Bull 3X Shares (LABU) short volume is 99.7K shares against 203.6K total reported volume, or 48.95% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is LABU short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does LABU short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.